InvestorsHub Logo
Followers 4
Posts 2010
Boards Moderated 0
Alias Born 09/19/2008

Re: laser777 post# 10946

Monday, 11/20/2017 9:21:06 PM

Monday, November 20, 2017 9:21:06 PM

Post# of 12137
Laser,

“The industry anticipates several commercial filings and/or launches during the current year, which include Kite’s KTE-C19, Spark Therapeutics’ Voretigene Neparvovec, Novartis’ CTL-019, TiGenix’s Cx601, and Kiadis Pharma’s ATIR101, many of which Cryoport is actively supporting. . .

We know that Kite and NVS are completed. Sparks/Voretigene are connected, CYRX customer? TiGenix is definitely a CYRX customer, they're close.. Kiadis?
Hyper presented the Juno news, my money is on Bluebird Bio to file soon..
ASCO in about 2 weeks or so.. JUNO, BLUE, NVS and BLCM high lighted as part of top 8 to watch..
Let's not forget, NVS 2nd indication..

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News